News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Crispr Therapeutics Ag
(NQ:
CRSP
)
45.52
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,920
Open
45.52
Bid (Size)
45.00 (2)
Ask (Size)
46.00 (2)
Prev. Close
45.52
Today's Range
45.52 - 45.52
52wk Range
37.55 - 91.10
Shares Outstanding
78,935,098
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Monster Biotech Stocks to Buy Before 2025
September 02, 2024
These companies are nearly in the sweet spot of risk versus reward in biotech.
Via
The Motley Fool
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
August 26, 2024
The companies are chasing major innovations.
Via
The Motley Fool
Performance
YTD
-31.09%
-31.09%
1 Month
-8.34%
-8.34%
3 Month
-21.89%
-21.89%
6 Month
-43.80%
-43.80%
1 Year
-9.43%
-9.43%
More News
Read More
Got the Market Sell-Off Blues? Do These 3 Things Right Now
August 11, 2024
Via
The Motley Fool
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
August 08, 2024
Via
Benzinga
7 Biotech Stocks to Buy for Their Game-Changing Potential
August 08, 2024
Via
InvestorPlace
The 3 Best Gene Editing Stocks to Buy in August 2024
August 07, 2024
Via
InvestorPlace
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
August 06, 2024
Via
The Motley Fool
CRSP Stock Earnings: CRISPR Therapeutics Beats EPS, Misses Revenue for Q2 2024
August 05, 2024
Via
InvestorPlace
Prediction: These Could Be the Best-Performing Growth Stocks Through 2030
August 05, 2024
Via
The Motley Fool
Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker
August 04, 2024
Via
The Motley Fool
3 Unstoppable Stocks to Buy in August
August 03, 2024
Via
The Motley Fool
10 Best Small and Mid-Cap Stocks to Consider Buying in August
August 01, 2024
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
July 31, 2024
Via
The Motley Fool
The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024
July 29, 2024
Via
InvestorPlace
3 Small-Cap Stocks to Buy at a 52-Week Low
July 27, 2024
Via
InvestorPlace
3 Gene Editing Stocks Shaping the Future of Medicine
July 22, 2024
Via
InvestorPlace
3 Monster Stocks in the Making to Buy Right Now
July 20, 2024
Via
The Motley Fool
3 Gene Editing Stocks That Could Grow Your Wealth
July 17, 2024
Via
InvestorPlace
3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition
July 17, 2024
Via
InvestorPlace
Blue Chips, Small Caps Extending Their Breakout
July 16, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
July 16, 2024
Via
The Motley Fool
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid
July 11, 2024
Via
The Motley Fool
Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates
July 11, 2024
Via
Benzinga
Topics
ETFs
3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
July 11, 2024
Via
MarketBeat
3 Profitable CRISPR Stocks Earning Analysts’ Praise
July 09, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close